Download PDF
Hamostaseologie 2003; 23(04): 159-169
DOI: 10.1055/s-0037-1619593
Original Article
Schattauer GmbH

Angeborene und erworbene Thrombozytopenien

Congenital and acquired thrombocytopenias
R. E. Scharf
1   Institut für Hämostaseologie und Transfusionsmedizin, Universitätsklinikum Heinrich-Heine-Universität Düsseldorf
› Author Affiliations
Further Information

Publication History

Publication Date:
20 January 2018 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Es wird ein Überblick über angeborene und erworbene Thrombozytopenien, ihre Pathophysiologie, Klinik, Diagnostik und Therapie gegeben. Insbesondere werden die heparininduzierte Thrombozytopenie vom Typ II (HIT II) und die thrombotisch-thrombozytopenische Purpura (TTP) dargestellt.

Summary

An overview is given on congenitial and acquired thrombocytopenias, their pathophysiology, symptoms, diagnosis and therapy with emphazising heparin-induced thrombocytopenia (HIT) and the thrombotic thrombocytopenic purpura (TTP).

Schlüsselwörter

Thrombozytopenie - HIT II - TTP

Keywords

Thrombocytopenia - HIT 2 - TTP
 

  • Literatur

  • 1 Anderson JC. Response of resistant idiopathic thrombocytopenic purpura to pulsed high-dose dexamethasone therapy. N Engl J Med 1994; 330: 1560-4.
    CrossrefPubMedGoogle Scholar
  • 2 Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med 2002; 346: 995-1008.
    CrossrefPubMedGoogle Scholar
  • 3 George JN, El-Harake MA, Raskob GE. Chronic idiopathic thrombocytopenic purpura. N Engl J Med 1994; 331: 1207-11.
    CrossrefPubMedGoogle Scholar
  • 4 George JN, Woolf SH, Raskob GE. et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996; 88: 3-40.
    PubMedGoogle Scholar
  • 5 Joist JH, George JN. Acquired hemostatic abnormalities in liver and renal disease. In: Colman RW, Hirsh J, Marder VJ. et al (eds). Hemostasis and Thrombosis. Basic Principles and Clinical Practice. Philadelphia: Lippincott, Williams and Wilkins; 2001: 955-73.
    Google Scholar
  • 6 Law C, Marcaccio M, Tam P. et al. High-dose intravenous immune globuline and the response to splenectomy in patients with idiopathic thrombocytopenic purpura. N Engl J Med 1997; 336: 1494-8.
    CrossrefPubMedGoogle Scholar
  • 7 McMillan R. Therapy for adults with refractory chronic immune thrombocytopenic purpura. Ann Intern Med 1997; 126: 307-14.
    CrossrefPubMedGoogle Scholar
  • 8 Moake JL. Thrombotic microangiopathies. N Engl J Med 2002; 347: 589-600.
    CrossrefPubMedGoogle Scholar
  • 9 Mueller-Eckhardt C, Scharf RE. Thrombozytäre hämorrhagische Diathesen. In: Begemann H, Rastetter J. (Hrsg). Klinische Hämatologie. Stuttgart: Thieme; 1993: 870-949.
    Google Scholar
  • 10 Warkentin TE, Chong BH, Greinacher A. Heparin-induced thrombocytopenia: toward consensus. Thrombos Haemost 1998; 79: 1-7.
    PubMedGoogle Scholar
  • 11 Warkentin TE. Heparin-induced thrombocytopenia: yet another treatment paradox?. Thromb Haemost 2001; 85: 947-9.
    Article in Thieme ConnectPubMedGoogle Scholar